Aquestive Therapeutics, Inc. (AQST)
Nasdaq: AQST · Pharmaceutical Preparations · Warren, NJ · filing with the SEC since 2007
Who owns Aquestive Therapeutics, Inc.
As filed with the SECHolders of 5% or more
3
Bass Edward P holds 7.5% of Common Stock, Par Value $0.001 Per Share, as its SCHEDULE 13G filed Oct 7, 2026 says.
Directors and officers
18
report now, of 30 people on the record since 2018. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Bass Edward P
SCHEDULE 13G · filed Oct 7, 2026 · Common Stock, Par Value $0.001 Per Share
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 27, 2026 · Common Stock · 5.3% in Oct 17, 2025
RTW Investments, LP
SCHEDULE 13G · filed Nov 14, 2025 · Common Stock, $0.001 par value
Venrock Healthcare Capital Partners III, L.P.
SCHEDULE 13G/A · filed Feb 14, 2025 · Common stock, $0.001 par value per share · reported falling below 5%
Bratton Douglas K
SCHEDULE 13G/A · filed Oct 7, 2026 · Common Stock, Par Value $0.001 Per Share · reported falling below 5%, from 11.1% in Feb 13, 2025
What AQST reports owning in othersstakes of 5% or more, and other ties
Aquestive Therapeutics, Inc. reports no stake in another company in the record.
Insider tradesForm 4
16sales
2purchases
9sales on a scheduled plan
8people selling
$2.4Msold, in dollars
$100,000bought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window9 of 38 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Barber Daniel | President and CEO | 8 | $1.3M | 7 | 0 | $0 |
| Toth A Ernest Jr | Chief Financial Officer | 1 | $200,000 | 0 | 0 | $0 |
| Jung Cassie | Chief Operating Officer | 1 | $200,000 | 0 | 0 | $0 |
| Braender Lori J | Corporate Secretary | 1 | $200,000 | 0 | 0 | $0 |
| Korczynski Sherry | Chief Commercial Officer | 2 | $100,000 | 1 | 0 | $0 |
| Boyd Peter E. | Chief People Officer | 1 | $100,000 | 0 | 0 | $0 |
| Cioffi Melina | SVP, Regulatory Affairs | 1 | $100,000 | 0 | 0 | $0 |
| Krop Julie | director | 1 | $100,000 | 1 | 0 | $0 |
| Daly Richard J | director | 0 | $0 | 0 | 2 | $100,000 |